Be Interested, Be Very Interested in mentax.
Click on image below to visit mentax Online Page
FOSTER CITY, Calif.–(BUSINESS WIRE)–Oct. 24, 1996–Penederm Incorporated (NASDAQ:DERM) today announced that it has received marketing clearance from the U.S. Food and Drug Administration (FDA) for MENTAX, the Company’s 1% butenafine hydrochloride cream.
MENTAX prescription topical antifungal is indicated for use against interdigital tinea pedis (athlete’s foot), the largest segment of the $350 million U.S. prescription topical antifungal market. Schering-Plough HealthCare Products, Inc. will co-promote MENTAX with Penederm in the United States.
“Marketing approval for the first prescription dermatological product in our portfolio is a significant milestone for Penederm,” said Lloyd H. Malchow, President and Chief Executive Officer of Penederm Incorporated. “MENTAX is an exciting, new once-a-day antifungal drug that has been extremely well-received by the clinicians who participated in the clinical trials.”
Malchow noted that the Company plans to market MENTAX in the United States through a pharmaceutical specialty contract sales force dedicated to Penederm products. For the first year, the sales force is expected to consist of more than 40 sales representatives, who plan to make over 50,000 calls on physicians who are high prescribers of dermatologic products. Schering-Plough HealthCare Products, Inc. will co-promote MENTAX to the podiatry market in the United States.
Advertisement
Cheap mentax tablets from the Best!
Advises of Dr.Rendall to buy mentax.
Med talks about new mentax.
Lowest pirices for mentax found here!
Lowest pirices for mentax found here!
Learn more about mentax.
Healthier You - get mentax.